SRC and plasma cell myeloma: Moreover, a significant reduction of phospho-JAK2 and Src, the upstream tyrosine kinases of STAT3, was observed in Icariside II-treated U937 cells in a dose- and time-dependent manner, which was similarly supported by our previous report in multiple myeloma cells [5].